{"entity":{"id":"ludwig-cancer-research","kind":"institution","name":"Ludwig Cancer Research","aka":["Ludwig Institute for Cancer Research","LICR"],"tldr":"The cancer research institute that shipping magnate Daniel K. Ludwig endowed in 1971 with nearly all of his international holdings; it has spent more than $1.8 billion of its own money on cancer science.","summary":"Founded in 1971, the Ludwig Institute for Cancer Research is an international not-for-profit that funds and runs its own laboratories rather than making grants from donations. Its own account states that it has invested more than $1.8 billion of its resources in cancer research and holds an endowment valued at $1.5 billion. In 2006 the Ludwig gift also created Ludwig Centers and professorships at six leading US institutions, each with more than $2 million a year in perpetuity. Ludwig scientists worked on the biology that became checkpoint immunotherapy, on tumour antigens and on cancer genomics. Headquartered in New York with historic roots in Zurich.","asOf":"2026-09-10","links":[{"label":"About Ludwig Cancer Research","url":"https://www.ludwigcancerresearch.org/about/"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":["immunotherapy","checkpoint-inhibitor","cgp"],"targets":[],"drugs":[],"companies":[],"institutions":["mskcc","mit-koch","stanford","uchicago-cancer","johns-hopkins"],"pathways":[],"terms":[],"trials":[],"people":["daniel-ludwig"],"bottlenecks":["b-funding-allocation","b-translational-valley"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"New York","country":"US","lat":40.751,"lng":-73.975,"institutionType":"research-institute","website":"https://www.ludwigcancerresearch.org","programs":["Ludwig Institute branches","Ludwig Centers at six US institutions (since 2006)","Cancer immunology and tumour antigens","Cancer genomics and metabolism"]},"route":"/institutions/ludwig-cancer-research/","neighbours":{"section":[{"id":"immunotherapy","kind":"section","name":"Immunotherapy","route":"/fronts/immunotherapy/"}],"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"}],"institution":[{"id":"mit-koch","kind":"institution","name":"David H. Koch Institute for Integrative Cancer Research at MIT","route":"/institutions/mit-koch/"},{"id":"johns-hopkins","kind":"institution","name":"Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center","route":"/institutions/johns-hopkins/"},{"id":"mskcc","kind":"institution","name":"Memorial Sloan Kettering Cancer Center","route":"/institutions/mskcc/"},{"id":"stanford","kind":"institution","name":"Stanford Health Care / Stanford Cancer Institute","route":"/institutions/stanford/"},{"id":"uchicago-cancer","kind":"institution","name":"University of Chicago Medicine Comprehensive Cancer Center","route":"/institutions/uchicago-cancer/"}],"person":[{"id":"daniel-ludwig","kind":"person","name":"Daniel K. Ludwig","route":"/people/daniel-ludwig/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-translational-valley","kind":"bottleneck","name":"The valley of death between lab and product","route":"/bottlenecks/b-translational-valley/"}]}}